60 Degrees Pharmaceuticals, Inc.
SXTP· Nasdaq
Released Aug 13, 2025, during market hours
10-Q filed Aug 13, 2025, 44 days after period end · 0001554855-25-001009
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $100.93K | $124.97K | $59.53K | $45.17K |
| Net Income | -$1.73M | -$4.17M | -$3.34M | -$2.15M |
| EPS Diluted | -$5.01 |
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
| -$21.12 |
| -$16.84 |
| -$0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.